EthicalMedTech is a platform, supported by MedTech Europe, dedicated to ethics and compliance projects in the MedTech industry.
The International Congress of Cannabinoid Medicine is found COMPLIANT with the MedTech Europe Code of Ethical Business Practice.
The assessment decision is available here.
WHAT IS THE MEDTECH EUROPE CODE?
Important updates about the Code of Ethics
A code for more transparency, effective 1st January 2018
The MedTech Europe Code of Ethical Business Practice regulates all aspects of the industry’s relationships with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs).
One important change introduced by the Code as of 1 January 2018 is discontinuation of direct sponsorship of HCPs. As of that date, independent medical education has to be supported exclusively by means of Educational Grants. Such Educational Grants can be provided to HCOs and PCOs.
Kenes Group is officially recognised by MedTech Europe as a compliant, trusted PCO to rely on in the process of organising medical educational events.
WHAT DOES THIS MEAN FOR THE SUPPORT OF the International Congress of Cannabinoid Medicine?
Educational Participation Grants
As a trusted partner, Kenes Group will take on the responsibility for indirect sponsorship for the International Congress of Cannabinoid Medicine. The industry will entrust the Kenes Group and provide educational grants directly, and Kenes Group/International Congress of Cannabinoid Medicine will be responsible for participants (HCPs) pre-selection.
Educational Participation Grants of any amount are appreciated and important to the success of the International Congress of Cannabinoid Medicine.
Recipients (HCPs) will need to fulfill the criteria specified by the International Congress of Cannabinoid Medicine in order to be eligible to apply for an educational participation grant. Accepted grant recipients will be contacted by the International Congress of Cannabinoid Medicine Secretariat.
I’m a European MedTech Industry partner and I want to support medical education at the International Congress of Cannabinoid Medicine. Contact Industry Liaison here.